These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10972232)

  • 1. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus.
    Khanna AK
    Transplantation; 2000 Aug; 70(4):690-4. PubMed ID: 10972232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of cyclosporin A to induce transforming growth factor beta (TGF-beta) synthesis in activated peripheral blood lymphocytes.
    Goppelt-Struebe M; Esslinger B; Kunzendorf U
    Clin Transplant; 2003 Feb; 17(1):20-5. PubMed ID: 12588317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.
    Khanna A; Cairns V; Hosenpud JD
    Transplantation; 1999 Feb; 67(4):614-9. PubMed ID: 10071036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW; Imamura M; Hashino S; Zhu X; Tanaka J; Imai K; Matsudaira T; Asano S
    Bone Marrow Transplant; 1995 May; 15(5):733-9. PubMed ID: 7545487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription.
    Rolfe FG; Valentine JE; Sewell WA
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
    Waller JR; Brook NR; Bicknell GR; Murphy GJ; Nicholson ML
    Transplant Proc; 2005; 37(1):164-6. PubMed ID: 15808582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
    Kyles AE; Gregory CR; Craigmill AL
    Am J Vet Res; 2000 Aug; 61(8):906-9. PubMed ID: 10951980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction.
    Nelson PA; Kawamura A; Akselband Y; Peattie DA; Aldape RA; Harding MW
    Transplant Proc; 1991 Dec; 23(6):2867-9. PubMed ID: 1721299
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia.
    Waller JR; Brook NR; Bicknell GR; Nicholson ML
    Transpl Int; 2004 Jan; 17(1):9-14. PubMed ID: 14551676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine.
    Khanna AK; Cairns VR; Becker CG; Hosenpud JD
    Transplantation; 1999 Mar; 67(6):882-9. PubMed ID: 10199738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
    Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
    Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
    Pockley AG; Williams S; Reid SD; Bowles MJ
    Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production.
    Jørgensen PF; Wang JE; Almlöf M; Solberg R; Okkenhaug C; Scholz T; Thiemermann C; Foster SJ; Aasen AO
    Scand J Immunol; 2001 Feb; 53(2):184-91. PubMed ID: 11169223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
    Mattila PS
    Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro.
    Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J
    Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
    Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
    Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.